Calculus Bovis Sativus for Stroke Recovery
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests an investigational traditional Chinese medicine called Calculus Bovis Sativus (CBS) for people who have had an ischemic stroke or have small vessel disease in the brain. It aims to see if CBS can help recovery and is safe to use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You have had an ischemic stroke (with a score between 1 and 24 on the NIH stroke scale) or have small vessel disease seen on MRI.
- Your symptoms must have been stable for at least 30 days before the study starts.
- You are not pregnant, not planning pregnancy, and willing to use birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a type of non-invasive brain stimulation called intermittent theta burst stimulation can improve memory and thinking in people whose cognitive problems are caused by cerebral small vessel disease (damage to the small blood vessels in the brain). You may qualify if you have mild memory or thinking issues that have lasted at least three months.
This trial tests whether a cholesterol-lowering medication called evolocumab (a PCSK9 inhibitor) can help people recover better after a specific type of stroke caused by clogged arteries. The study checks if lowering cholesterol further than usual statins do improves stroke outcomes and is safe.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
This trial tests an investigational drug called B2065 for people who have had a recent ischemic stroke (a stroke caused by a blockage in a blood vessel in the brain). The goal is to see if it is safe and if it might help improve recovery when given within 36 hours of stroke symptoms starting.
This trial tests if a combination of two oral drugs (isosorbide mononitrate and butylphthalide) can reduce long-term disability after a specific type of mild stroke called a lacunar stroke. Participants must have had the stroke within the last week and be generally healthy otherwise.
This study looks at how blood flow in small brain blood vessels changes after a stroke or in cerebral small vessel disease. It may help doctors better understand and treat these conditions.
Hear when a new Ischemic Cerebrovascular Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.